UPDATE: Danaher Q1 Revenues Rise 5 Percent; CEO Culp Retiring Next Year | GenomeWeb

The story has been updated to include comments from Danaher's conference call.

NEW YORK (GenomeWeb News) – Danaher said after the close of the market on Wednesday that total revenues for the first quarter increased 5 percent year over year as revenues from its Life Sciences and Diagnostics segment rose nearly 6 percent.

The company also announced that its President and CEO Lawrence Culp will retire on March 1, 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.